Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

Post-Radiation Cystitis and Sexual Dysfunction: Understanding and Ma…

European Society for Sexual Medicine

M. Fode

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

TRAVERSE Trial: Prostate Safety Events

Androgen Society

A. Morgentaler

Year in Review: Cutting Edge Advances in Kidney Cancer - Imaging and…

Ketan Badani

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

Year in Review 2024 - Bladder Cancer

Oncology 2024 Year in Review

G. Sonpavde

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Advances in Prostate Cancer Surgery

Penn Medicine Abramson Cancer Center

B. Schurhamer, T. Guzzo

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

Year in Review 2024 - Renal Cell Carcinoma

Oncology 2024 Year in Review

N. Mar

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou